[
  {
    "ts": "2025-10-14T14:49:58+00:00",
    "headline": "Regeneron’s Q3 2025 Earnings: What to Expect",
    "summary": "Regeneron is expected to announce its fiscal third-quarter earnings later this month, and analysts project a double-digit earnings decline.",
    "url": "https://www.barchart.com/story/news/35436292/regenerons-q3-2025-earnings-what-to-expect",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "35931163-f8a5-35a2-82c8-59929c8cdd74",
      "content": {
        "id": "35931163-f8a5-35a2-82c8-59929c8cdd74",
        "contentType": "STORY",
        "title": "Regeneron’s Q3 2025 Earnings: What to Expect",
        "description": "",
        "summary": "Regeneron is expected to announce its fiscal third-quarter earnings later this month, and analysts project a double-digit earnings decline.",
        "pubDate": "2025-10-14T14:49:58Z",
        "displayTime": "2025-10-14T14:49:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/b5fca612b3a61a67a2a2b488a7827af2",
          "originalWidth": 1000,
          "originalHeight": 750,
          "caption": "Regeneron Pharmaceuticals, Inc_ logo on phone-by Piotr Swat via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/13cIDE5L8IVJcjoF_eSu9Q--~B/aD03NTA7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/b5fca612b3a61a67a2a2b488a7827af2.cf.webp",
              "width": 1000,
              "height": 750,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eAqOvAl854RedqYxYy.YBw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/b5fca612b3a61a67a2a2b488a7827af2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/35436292/regenerons-q3-2025-earnings-what-to-expect",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-q3-2025-earnings-expect-144958527.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-14T14:00:00+00:00",
    "headline": "2 Stocks Down 17% and 21% to Buy Right Now",
    "summary": "Both companies have faced recent challenges, but look likely to overcome them.",
    "url": "https://www.fool.com/investing/2025/10/14/2-stocks-down-15-and-18-to-buy-right-now/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f1850e04-36cd-320e-ab79-3a3c358720f8",
      "content": {
        "id": "f1850e04-36cd-320e-ab79-3a3c358720f8",
        "contentType": "STORY",
        "title": "2 Stocks Down 17% and 21% to Buy Right Now",
        "description": "",
        "summary": "Both companies have faced recent challenges, but look likely to overcome them.",
        "pubDate": "2025-10-14T14:00:00Z",
        "displayTime": "2025-10-14T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/82442c9d164402255289ad70a57eb29d",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Person using a CGM system.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nIMEUKFxgD7B61ElQsp0JQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/82442c9d164402255289ad70a57eb29d.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4dExSqUPbHzM1hwPHxaN7Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/82442c9d164402255289ad70a57eb29d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/14/2-stocks-down-15-and-18-to-buy-right-now/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-stocks-down-17-21-140000721.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]